Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
Abstract
Article abstract The authors report a new side effect of the dopamine agonists pramipexole and ropinirole: sudden irresistible attacks of sleep. Eight PD patients taking pramipexole and one taking ropinirole fell asleep while driving, causing accidents. Five experienced no warning before falling asleep. The attacks ceased when the drugs were stopped. Neurologists who prescribe these drugs and patients who take them should be aware of this possible side effect.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Gottwald MD, Bainbridge JL, Dowling GA, Aminoff MJ, Alldredge BK. New pharmacotherapy for Parkinson’s disease. Ann Pharmacother 1997;31:1205–1217.
2.
Parkinson Study Group.Safety and efficacy of pramipexole in early Parkinson’s disease. JAMA 1997;278:125–130.
3.
Sethi KD, O’Brien CF, Hammerstad JP, et al. Ropinirole for the treatment of early Parkinson’s disease. Arch Neurol 1998;55:1211–1216.
4.
Rye DB, Bliwise DL. Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. In: Watts RL, Koller WC, eds. Movement disorders. New York:McGraw-Hill, 1997:687–713.
5.
Fry JM. Treatment modalities for narcolepsy. Neurology 1998;50 (suppl 1):S43–S48.
Information & Authors
Information
Published In
Copyright
© 1999.
Publication History
Received: December 22, 1998
Accepted: February 26, 1999
Published online: June 1, 1999
Published in print: June 1, 1999
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- An overview of the effects of levodopa and dopaminergic agonists on sleep disorders in Parkinson’s disease, Journal of Clinical Sleep Medicine, 19, 6, (1133-1144), (2023).https://doi.org/10.5664/jcsm.10450
- Parkinson’s Disease: A Narrative Review on Potential Molecular Mechanisms of Sleep Disturbances, REM Behavior Disorder, and Melatonin, Brain Sciences, 13, 6, (914), (2023).https://doi.org/10.3390/brainsci13060914
- Chaudhuri’s Dashboard of Vitals in Parkinson’s syndrome: an unmet need underpinned by real life clinical tests, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1174698
- Awareness of medical issues in health sciences and in scientific technological education, IP Journal of Nutrition, Metabolism and Health Science, 6, 3, (106-109), (2023).https://doi.org/10.18231/j.ijnmhs.2023.018
- Parkinson’s disease. Focus on early stages, Neurology, Neuropsychiatry, Psychosomatics, 15, 3, (95-103), (2023).https://doi.org/10.14412/2074-2711-2023-3-95-103
- Clinical Manifestations of Subjective Sleep Disorders in Chinese Patients with Parkinson’s Disease and Their Relationship with Dopaminergic Drugs, European Neurology, (1-10), (2023).https://doi.org/10.1159/000533905
- The Park Sleep subtype in Parkinson’s disease: from concept to clinic, Expert Opinion on Pharmacotherapy, 24, 15, (1725-1736), (2023).https://doi.org/10.1080/14656566.2023.2242786
- The complex molecular pharmacology of the dopamine D2 receptor: Implications for pramipexole, ropinirole, and rotigotine, Pharmacology & Therapeutics, 245, (108392), (2023).https://doi.org/10.1016/j.pharmthera.2023.108392
- Sleepiness in neurological disorders, Revue Neurologique, 179, 7, (755-766), (2023).https://doi.org/10.1016/j.neurol.2023.07.005
- Parkinsonian daytime sleep-wake classification using deep brain stimulation lead recordings, Neurobiology of Disease, 176, (105963), (2023).https://doi.org/10.1016/j.nbd.2022.105963
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to get full access to it.